Response to Secukinumab after Treatment Failure with Ustekinumab in 6 Patients with Plaque Psoriasis

Actas Dermosifiliogr (Engl Ed). 2018 Jul-Aug;109(6):565-567. doi: 10.1016/j.ad.2017.07.019. Epub 2017 Nov 21.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Remission Induction
  • Retrospective Studies
  • Treatment Failure
  • Ustekinumab / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • secukinumab
  • Ustekinumab